Free Trial

Adage Capital Partners GP L.L.C. Increases Stock Holdings in Constellium SE (NYSE:CSTM)

Constellium logo with Industrials background

Adage Capital Partners GP L.L.C. boosted its position in shares of Constellium SE (NYSE:CSTM - Free Report) by 70.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 298,774 shares of the industrial products company's stock after purchasing an additional 123,774 shares during the period. Adage Capital Partners GP L.L.C. owned about 0.20% of Constellium worth $3,068,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of the company. T. Rowe Price Investment Management Inc. boosted its position in Constellium by 26.7% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 19,828,738 shares of the industrial products company's stock valued at $203,642,000 after purchasing an additional 4,181,823 shares during the last quarter. Dark Forest Capital Management LP bought a new stake in Constellium in the 4th quarter valued at $231,000. Beacon Investment Advisors LLC lifted its holdings in Constellium by 1.6% during the 4th quarter. Beacon Investment Advisors LLC now owns 311,179 shares of the industrial products company's stock valued at $3,196,000 after purchasing an additional 5,046 shares during the last quarter. MetLife Investment Management LLC raised its position in shares of Constellium by 2.7% in the fourth quarter. MetLife Investment Management LLC now owns 76,659 shares of the industrial products company's stock valued at $787,000 after purchasing an additional 1,989 shares during the period. Finally, Mariner LLC acquired a new position in shares of Constellium in the fourth quarter valued at approximately $107,000. 92.59% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft upgraded shares of Constellium from a "hold" rating to a "buy" rating and set a $15.00 target price on the stock in a research report on Tuesday, February 25th.

View Our Latest Stock Analysis on CSTM

Constellium Price Performance

Shares of NYSE CSTM traded up $0.14 during mid-day trading on Monday, hitting $11.28. 392,810 shares of the stock traded hands, compared to its average volume of 1,642,285. The company has a market cap of $1.61 billion, a PE ratio of 35.23 and a beta of 1.65. Constellium SE has a twelve month low of $7.32 and a twelve month high of $22.00. The company has a debt-to-equity ratio of 1.93, a current ratio of 1.28 and a quick ratio of 0.52. The firm has a 50 day simple moving average of $10.12 and a two-hundred day simple moving average of $10.67.

Constellium (NYSE:CSTM - Get Free Report) last announced its earnings results on Wednesday, April 30th. The industrial products company reported $0.26 earnings per share for the quarter, topping analysts' consensus estimates of $0.07 by $0.19. Constellium had a net margin of 0.67% and a return on equity of 4.83%. The business had revenue of $1.98 billion during the quarter, compared to the consensus estimate of $1.88 billion. During the same quarter last year, the firm earned $0.11 earnings per share. Constellium's quarterly revenue was up 5.3% on a year-over-year basis. As a group, equities research analysts forecast that Constellium SE will post 1.1 EPS for the current fiscal year.

Constellium Company Profile

(Free Report)

Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.

Featured Stories

Institutional Ownership by Quarter for Constellium (NYSE:CSTM)

Should You Invest $1,000 in Constellium Right Now?

Before you consider Constellium, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Constellium wasn't on the list.

While Constellium currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns
ACT FAST! Congress Is POURING Into This Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines